Latest filing published 24 Jul 2023 for NFL Biosciences, €17k. Read the official filing
No signal scores available.
Ignacio Faus, listed as chief executive, appears in our data through filings on NFL Biosciences shares, published by AMF. Over a trading history stretching from 24 April 2023 to 18 July 2023, the count stands at 2 filings.
The open-market record consists of 1 sale worth €17k, with no purchase. Outside the open market, there are 1 share grant.
On 24 July 2023 came the latest disclosure, an open-market sale for €17k in NFL Biosciences. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from AMF. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations